Nörotransmitter Bozuklukları ve Görüntüleme Bulguları

Brennenstuhl H, Jung-Klawitter S, Assmann B, Opladen T. Inherited Disorders of Neurotransmitters: Classification and Practical Approaches for Diagnosis and Treatment. Neuropediatrics. 2019;50(1):2-14. doi:10.1055/s-0038-1673630

Kurian MA, Gissen P, Smith M, Heales S Jr, Clayton PT. The monoamine neurotransmitter disorders: an expanding range of neurological syndromes. Lancet Neurol. 2011;10(8):721-733. doi:10.1016/S1474-4422(11)70141-7

Teleanu RI, Niculescu AG, Roza E, Vladâcenco O, Grumezescu AM, Teleanu DM. Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System. Int J Mol Sci. 2022;23(11):5954. Published 2022 May 25. doi:10.3390/ijms23115954

Opladen, T., Hoffmann, G.F. (2022). Disorders of Monoamine Metabolism. In: Blau, N., Dionisi Vici, C., Ferreira, C.R., Vianey-Saban, C., van Karnebeek, C.D.M. (eds) Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-67727-5_19

Opladen T, Cortès-Saladelafont E, Mastrangelo M, et al. The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders. Mol Genet Metab Rep. 2016;9:61-66. Published 2016 Oct 20. doi:10.1016/j.ymgmr.2016.09.006

García-Cazorla, Á., Artuch, R., Pearl, P.L. (2022). Disorders of Neurotransmission. In: Saudubray, JM., Baumgartner, M.R., García-Cazorla, Á., Walter, J. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63123-2_30

Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J. 2011;438(3):397-414. doi:10.1042/BJ20110293

Blau, Nenad; van Spronsen, Francjan J (2014). Disorders of Phenylalanine and Tetrahydrobiopterin Metabolism. In: Blau, N; Duran, M; Gibson, K M; Dionisi-Vici, C. Physician's Guide to the Diagnosis, Treatment, and Follow-up of Inherited Metabolic Diseases. s.n.: Springer-Verlag, 3-21.

Pearl PL, Capp PK, Novotny EJ, Gibson KM. Inherited disorders of neurotransmitters in children and adults. Clin Biochem. 2005;38(12):1051-1058. doi:10.1016/j.clinbiochem.2005.09.012

Jaeken J, Casaer P, de Cock P, et al. Gamma-aminobutyric acid-transaminase deficiency: a newly recognized inborn error of neurotransmitter metabolism. Neuropediatrics. 1984;15(3):165-169. doi:10.1055/s-2008-1052362

Pearl PL, Wiwattanadittakul N, Roullet JB, et al. Succinic Semialdehyde Dehydrogenase Deficiency. 2004 May 5 [Updated 2016 Apr 28]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1195/

Leo S, Capo C, Ciminelli BM, et al. SSADH deficiency in an Italian family: a novel ALDH5A1 gene mutation affecting the succinic semialdehyde substrate binding site. Metab Brain Dis. 2017;32(5):1383-1388. doi:10.1007/s11011-017-0058-5

Casarano M, Alessandrì MG, Salomons GS, et al. Efficacy of vigabatrin intervention in a mild phenotypic expression of succinic semialdehyde dehydrogenase deficiency. JIMD Rep. 2012;2:119-123. doi:10.1007/8904_2011_60

Didiasova M, Banning A, Brennenstuhl H, Jung-Klawitter S, Cinquemani C, Opladen T, Tikkanen R. Succinic Semialdehyde Dehydrogenase Deficiency: An Update. Cells. 2020; 9(2):477. https://doi.org/10.3390/cells9020477

Chatron N, Becker F, Morsy H, et al. Bi-allelic GAD1 variants cause a neonatal onset syndromic developmental and epileptic encephalopathy. Brain. 2020;143(5):1447-1461. doi:10.1093/brain/awaa085

McHale DP, Mitchell S, Bundey S, Moynihan L, Campbell DA, Woods CG, et al. A gene for autosomal recessive symmetrical spastic cerebral palsy maps to chromosome 2q24-25. Am J Hum Genet 1999; 64: 526–32.

Addington AM, Gornick M, Duckworth J, Sporn A, Gogtay N, Bobb A, et al. GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol Psychiatry 2005; 10: 581–8.

Macdonald RL, Kang JQ, Gallagher MJ. Mutations in GABAA receptor subunits associated with genetic epilepsies. J Physiol. 2010;588(Pt 11):1861-1869. doi:10.1113/jphysiol.2010.186999

Carvill GL, McMahon JM, Schneider A, et al. Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures. Am J Hum Genet. 2015;96(5):808-815. doi:10.1016/j.ajhg.2015.02.016

Goodspeed K, Demarest S, Johannesen K, et al. SLC6A1-Related Neurodevelopmental Disorder. 2023 Feb 9. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK589173/

Palmer S, Towne MC, Pearl PL, et al. SLC6A1 Mutation and Ketogenic Diet in Epilepsy With Myoclonic-Atonic Seizures. Pediatr Neurol. 2016;64:77-79. doi:10.1016/j.pediatrneurol.2016.07.012

Traynelis SF, Wollmuth LP, McBain CJ, et al. Glutamate receptor ion channels: structure, regulation, and function [published correction appears in Pharmacol Rev. 2014 Oct;66(4):1141]. Pharmacol Rev. 2010;62(3):405-496. doi:10.1124/pr.109.002451

Soto D, Altafaj X, Sindreu C, Bayés A. Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. Commun Integr Biol. 2014;7(1):e27887. doi:10.4161/cib.27887

Soto D, Olivella M, Grau C, et al. L-Serine dietary supplementation is associated with clinical improvement of loss-of-function GRIN2B-related pediatric encephalopathy. Sci Signal. 2019;12(586):eaaw0936. Published 2019 Jun 18. doi:10.1126/scisignal.aaw0936

Wolf NI, Zschocke J, Jakobs C, Rating D, Hoffmann GF. ATAD1 encephalopathy and stiff baby syndrome: a recognizable clinical presentation. Brain. 2018;141(6):e49. doi:10.1093/brain/awy095

Molinari F, Raas-Rothschild A, Rio M, et al. Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy. Am J Hum Genet. 2005;76(2):334-339. doi:10.1086/427564

Van Hove JLK, Coughlin C II, Swanson M, et al. Nonketotic Hyperglycinemia. 2002 Nov 14 [Updated 2019 May 23]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1357/

Van Hove, J.L.K., Van Coster, R. (2022). Nonketotic Hyperglycinaemia and Lipoate Deficiency Disorders. In: Saudubray, JM., Baumgartner, M.R., García-Cazorla, Á., Walter, J. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63123-2_23

Stence NV, Fenton LZ, Levek C, et al. Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype. J Inherit Metab Dis. 2019;42(3):438-450. doi:10.1002/jimd.12072

Heindel W, Kugel H, Roth B. Noninvasive detection of increased glycine content by proton MR spectroscopy in the brains of two infants with nonketotic hyperglycinemia. AJNR Am J Neuroradiol. 1993;14(3):629-635.

Stence NV, Fenton LZ, Levek C, et al. Brain imaging in classic nonketotic hyperglycinemia: Quantitative analysis and relation to phenotype. J Inherit Metab Dis. 2019;42(3):438-450. doi:10.1002/jimd.12072

Wortmann SB, Mayr JA. Choline-related-inherited metabolic diseases-A mini review [published correction appears in J Inherit Metab Dis. 2020 Jan;43(1):156]. J Inherit Metab Dis. 2019;42(2):237-242. doi:10.1002/jimd.12011

Bauché S, O'Regan S, Azuma Y, et al. Impaired Presynaptic High-Affinity Choline Transporter Causes a Congenital Myasthenic Syndrome with Episodic Apnea. Am J Hum Genet. 2016;99(3):753-761. doi:10.1016/j.ajhg.2016.06.033

Abicht A, Müller JS, Lochmüller H. Congenital Myasthenic Syndromes Overview. 2003 May 9 [Updated 2021 Dec 23]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1168/

Siu WK. Genetics of monoamine neurotransmitter disorders. Transl Pediatr. 2015;4(2):175-180. doi:10.3978/j.issn.2224-4336.2015.03.01

Köse M, Çoker M. Primary NeurotransmitterMetabolism Disorders. Anatol J Med . 2017; 27(3): 169-178. doi: 10.5222/terh.2017.169

Furukawa Y, Kish S. Tyrosine Hydroxylase Deficiency. 2008 Feb 8 [Updated 2017 May 11]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1437/

Zafeiriou DI, Willemsen MA, Verbeek MM, Vargiami E, Ververi A, Wevers R. Tyrosine hydroxylase deficiency with severe clinical course. Mol Genet Metab. 2009;97(1):18-20. doi:10.1016/j.ymgme.2009.02.001

Blau N, Pearson TS, Kurian MA, et al. Aromatic L-Amino Acid Decarboxylase Deficiency. 2023 Oct 12. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK595821/

Senard JM, Rouet P. Dopamine beta-hydroxylase deficiency. Orphanet J Rare Dis. 2006;1:7. Published 2006 Mar 30. doi:10.1186/1750-1172-1-7

Garland EM, Biaggioni I. Dopamine Beta-Hydroxylase Deficiency. 2003 Sep 4 [Updated 2019 Apr 25]. In: Adam MP, Mirzaa GM, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1474/

Ng J, Papandreou A, Heales SJ, Kurian MA. Monoamine neurotransmitter disorders--clinical advances and future perspectives. Nat Rev Neurol. 2015;11(10):567-584. doi:10.1038/nrneurol.2015.172

Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol. 2003;54 Suppl 6:S32-S45. doi:10.1002/ana.10630

Segawa M. Autosomal dominant GTP cyclohydrolase I (AD GCH 1) deficiency (Segawa disease, dystonia 5; DYT 5). Chang Gung Med J. 2009;32(1):1-11.

Friedman J. Sepiapterin Reductase Deficiency. 2015 Jul 1. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK304122/

Ng J, Zhen J, Meyer E, et al. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood, Brain, Volume 137, Issue 4, April 2014, Pages 1107–1119, https://doi.org/10.1093/brain/awu022

Spaull RVV, Kurian MA. SLC6A3-Related Dopamine Transporter Deficiency Syndrome. 2017 Jul 27 [Updated 2023 Sep 28]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK442323/

Young AT, Ly KN, Wilson C, et al. Modelling brain dopamine-serotonin vesicular transport disease in Caenorhabditis elegans. Dis Model Mech. 2018;11(11):dmm035709. Published 2018 Nov 9. doi:10.1242/dmm.035709

Rilstone JJ, Alkhater RA, Minassian BA. Brain dopamine-serotonin vesicular transport disease and its treatment. N Engl J Med. 2013;368(6):543-550. doi:10.1056/NEJMoa1207281

Maritzen T, Haucke V. Coupling of exocytosis and endocytosis at the presynaptic active zone. Neurosci Res. 2018;127:45-52. doi:10.1016/j.neures.2017.09.013

Verhage M, Sørensen JB. SNAREopathies: Diversity in Mechanisms and Symptoms. Neuron. 2020;107(1):22-37. doi:10.1016/j.neuron.2020.05.036

Horvath GA, Stockler-Ipsiroglu SG, Salvarinova-Zivkovic R, et al. Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms. Mol Genet Metab. 2008;94(1):127-131. doi:10.1016/j.ymgme.2008.01.003

Opladen T, López-Laso E, Cortès-Saladelafont E, et al. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies [published correction appears in Orphanet J Rare Dis. 2020 Aug 5;15(1):202]. Orphanet J Rare Dis. 2020;15(1):126. Published 2020 May 26. doi:10.1186/s13023-020-01379-8

Burgard, P., Lachmann, R.H., Walter, J.H. (2022). Hyperphenylalaninaemia . In: Saudubray, JM., Baumgartner, M.R., García-Cazorla, Á., Walter, J. (eds) Inborn Metabolic Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-63123-2_16

Almannai M, Felemban R, Saleh MA, et al. 6-Pyruvoyltetrahydropterin Synthase Deficiency: Review and Report of 28 Arab Subjects. Pediatr Neurol. 2019;96:40-47. doi:10.1016/j.pediatrneurol.2019.02.008